🔎 Trials Near Me

Home › Vitiligo › NCT07659418

PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents

RecruitingObservational studyHealthy volunteers welcome

Who can join

Ages 12 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

Individuals are eligible for enrollment if they meet all of the following criteria:

* Have a dermatologist- or qualified dermatology practitioner-confirmed diagnosis of nonsegmental vitiligo (NSV).
* Is at least 12 years of age or older at the time of enrollment.
* Is willing and able to provide informed consent or assent, with parent/legal guardian consent as applicable.
* Adult participants are willing and able to provide required personal information

  • Full legal name, sex, date of birth, and home ZIP/postal code
* Meet the criteria for one of the following enrollment cohorts at the time of enrollment:

Cohort 1: Eligible Medication Initiators - Individuals initiating a prescribed eligible NSV medication at the time of enrollment.

Cohort 2: Not Initiating Eligible Medication - Individuals not currently receiving NSV medication at the time of enrollment, Individuals receiving eligible NSV medication prior to enrollment.

Exclusion Criteria:

An individual who meets any of the following criteria will be excluded from participation in the registry:

\- Is participating or planning to participate in a blinded clinical trial for a vitiligo therapy.

About the study

The design is a prospective, observational (non-interventional) registry for adolescent and adult subjects with NSV under the care of a dermatology provider.

Sponsor: CorEvitas · Participants: 2,500 · Started: Aug 21, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07659418

Locations in the U.S.

MassachusettsCorEvitas, LLC, Waltham

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.